NuVasive Next Generation NVM5 System— 510(k) K162313

Substantially Equivalent

Nu Vasive, Incorporated

FDA 510(k) clearance K162313 for NuVasive Next Generation NVM5 System, Substantially Equivalent on 2017-03-16. Applicant: Nu Vasive, Incorporated.

Clearance details

Applicant
Nu Vasive, Incorporated
Product code
Code PDQ
Advisory panel
Ear, Nose, Throat
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.